O36.0993 Maternal care for other rhesus isoimmunization, unspecified trimester, fetus 3

Name of the Condition

• Maternal care for other rhesus isoimmunization, unspecified trimester, fetus 3
• ICD Code: O36.0993

Summary

This condition involves medical care and monitoring provided to a pregnant woman who has developed antibodies against the Rh factor, excluding anti-D antibodies, during an unspecified trimester, specifically for a third fetus. The care focuses on managing potential risks to the fetus and ensuring maternal health, particularly when other Rh antibodies are present.

Causes

Rhesus isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal blood, typically during a previous pregnancy or delivery. This exposure triggers the mother's immune system to produce antibodies that can cross the placenta and attack the red blood cells of an Rh-positive fetus in subsequent pregnancies. In this case, the antibodies are not anti-D but other Rh-specific antibodies.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an Rh-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Blood typing and antibody screening to detect non-anti-D Rh antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Amniocentesis or cordocentesis may be used to evaluate fetal hemoglobin levels and bilirubin.

Treatment Options

• Close monitoring of maternal antibody levels and fetal well-being
• Intrauterine blood transfusions for severely affected fetuses
• Early delivery if fetal distress is detected
• Postnatal care for the newborn, including phototherapy or exchange transfusion

Prognosis and Follow-Up

Prognosis depends on the severity of fetal anemia and the timeliness of intervention. Regular follow-up is essential to monitor maternal antibody titers and fetal growth. Post-delivery care for the newborn may include monitoring for jaundice or anemia.

Complications

• Severe fetal anemia leading to hydrops fetalis
• Fetal death in untreated cases
• Neonatal jaundice requiring intensive care
• Long-term neurological complications if anemia is severe

Lifestyle & Prevention

• Rh-negative women should receive Rh immune globulin after any potential exposure to Rh-positive blood
• Avoid unnecessary invasive procedures during pregnancy
• Early prenatal care to detect and manage isoimmunization

When to Seek Professional Help

Seek immediate medical attention if experiencing abdominal pain, vaginal bleeding, or reduced fetal movement. Regular prenatal visits are critical for monitoring antibody levels and fetal health.

Tips for Medical Coders

Document the trimester (unspecified) and specify the fetus number (3) as part of the care context. Ensure the code reflects the maternal care for other rhesus isoimmunization, excluding anti-D antibodies, and aligns with the clinical scenario.